CD81 通过阻断 CD274/PD-L1 的选择性自噬降解驱动放射抵抗性胶质母细胞瘤的免疫逃逸
CD81 drives immune evasion in radioresistant glioblastoma by blocking selective autophagic degradation of CD274/PD-L1.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Evaluation of the impact of miR-3143 on the PI3K/AKT signaling pathway and its subsequent influence on the metastatic phenotype of triple-negative breast cancer cells.
Evaluation of the impact of miR-3143 on the PI3K/AKT signaling pathway and its subsequent influence on the metastatic phenotype of triple-negative breast cancer cells.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
微小RNA(miRNA)在多种癌症(包括三阴性乳腺癌[ TNBC ])的进展和转移播散中发挥重要作用。近期证据提示,特定miRNA可直接或间接影响TNBC的发生、进展和复发。既往研究发现TNBC中miR-3143常下调,且似乎伴随增殖信号通路激活,但miR-3143能否恢复并改变TNBC细胞行为尚未明确。
本研究利用外泌体递送miR-3143至TNBC细胞,考察其对PI3K/AKT通路及细胞增殖、迁移和凋亡的影响。研究以miR-3143电转的人脐带间充质干细胞(HUCMSC)来源外泌体处理MDA-MB-231 TNBC细胞,通过RT-qPCR检测其靶基因PIK3CA和AKT1的表达变化,并用双荧光素酶报告实验验证。
结果显示,miR-3143过表达可通过直接结合靶基因3′非翻译区(3′-UTR),有效降低AKT1和PIK3CA水平。将miR-3143导入TNBC细胞显著增强了细胞凋亡。HUCMSC来源外泌体递送miR-3143还可抑制TNBC细胞促肿瘤和促转移行为,可能限制其恶性进展。上述发现增进了对miR-3143调控TNBC细胞转移潜能机制的认识,并可能推动开发新的miRNA靶向策略,以应对TNBC的侵袭性并提高治疗效果。
MicroRNAs (miRNAs) are recognized to have a pivotal role in the progression and metastatic dissemination encompassing diverse cancer varieties, such as triple-negative breast cancer (TNBC). Recent evidence has suggested that specific miRNA species can directly or indirectly influence the onset, progression, and relapse of TNBC. Previous studies have reported the frequent reduction of miR-3143 in TNBC, which appears to coincide with the activation of proliferative signaling pathways.
However, the potential restorative effects of miR-3143 on TNBC cellular behavior remain unexplored. In the present study, we utilized exosome-mediated delivery to introduce miR-3143 into TNBC cells and investigated its impact on the PI3K/AKT pathway and the resulting effects on cellular proliferation, movement, and apoptosis.
MDA-MB-231 TNBC cells underwent treatment with miR-3143-electroporated human umbilical cord mesenchymal stem cell (HUCMSC)-derived exosomes. RT-qPCR analysis was utilized to assess the influence of miR-3143 overexpression on the expression of its target genes, PIK3CA and AKT1, which was further validated through dual-luciferase reporter assays.
Our results demonstrated that the overexpression of miR-3143 could effectively decline the level of AKT1 and PIK3CA by directly binding to their 3'-UTRs.
Furthermore, the introduction of miR-3143 into TNBC cells resulted in a significant enhancement of apoptotic activities. Interestingly, the delivery of miR-3143 via HUCMSC-derived exosomes could inhibit the protumorigenic and prometastatic behaviors of TNBC cells, potentially limiting their malignant progression.
Collectively, these findings enhance comprehension of the regulatory mechanisms by which miR-3143 can modulate the metastatic potential of TNBC cells. The insights gained from this study may facilitate the creation of innovative miRNA-targeting approaches to combat the aggressive nature of TNBC andstrengthen treatment effectiveness.
MEMBER ACCOUNT
登录成功会直接打开下一页。